Affinity Asset Advisors, LLC

SEC CIK: 0001773195
Latest filing: Aug 13, 2026

SEC filings (opens in a new tab)

SNDX holding history

Syndax Pharmaceuticals Inc in every 13F filed by Affinity Asset Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SNDX overview All 13F holders of SNDX Full Q2 2026 holdings

Shares (Q1 2023): 0; Sold out in Q1 2023
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q4 2021

Holdings of SNDX by Affinity Asset Advisors, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2023	0	$0	0.0%	−100,000−100.0%	Sold out	Holders
Q4 2022	100,000	$2.54M	1.2%	+100,000	New	Holders
Q1 2022	0	$0	0.0%	−175,000−100.0%	Sold out	Holders
Q4 2021	175,000	$3.83M	1.6%	+175,000	New	Holders